Citigroup’s Foundation Medicine, Inc. FMI Stock Holding History

Citigroup’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-33,900	Closed	-$4.63M	–	7988
2018 Q2	$4.63M	Buy	33,900 +23,700	+232%	+$2.15M	﹤0.01%	1904
2018 Q1	$803K	Sell	10,200 -9,600	-48%	-$708K	﹤0.01%	3469
2017 Q4	$1.35M	Buy	19,800 +15,900	+408%	+$825K	﹤0.01%	3036
2017 Q3	$157K	Sell	3,900 -300	-7%	-$11.6K	﹤0.01%	5191
2017 Q2	$167K	Sell	4,200 -300	-7%	-$11K	﹤0.01%	4944
2017 Q1	$145K	Buy	4,500 +3,200	+246%	+$79.8K	﹤0.01%	4925
2016 Q4	$23K	Buy	+1,300	New	+$28K	﹤0.01%	6480

Citigroup's FMI Position: Q3 2018 in Review

Citigroup sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 173,037 shares — an estimated $23.7M sold.

Citigroup first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $23.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Citigroup reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Citigroup sold 173,037 Foundation Medicine, Inc. shares in Q3 2018, an estimated $23.7M.
Citigroup first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
Citigroup's Foundation Medicine, Inc. position peaked at $23.7M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.